(i) international comparisons,
(ii) the capacity of the current legislative regime to
respond to new and emerging technologies which have implications for
privacy, including:
(A) ‘Smart Card’ technology and the potential for this to be
used to establish a national identification regime,
(B) biometric imaging data,
(C) genetic testing and the potential disclosure and
discriminatory use of such information, and
(D) microchips which can be implanted in human beings (for
example, as recently authorised by the United States Food and Drug
Administration), and
(iii) any legislative changes that may help to provide more
comprehensive protection or improve the current regime in any way;
(c) the resourcing of the
Office of the Federal Privacy Commissioner and whether current levels of
funding and the powers available to the Federal Privacy Commissioner enable
her to properly fulfil her mandate.